International Clinical Trial: Molecular Mechanisms and Clinical Translation of GSTM3-Regulated Lipid Metabolic Reprogramming for the Treatment of Non-Alcoholic Fatty Liver Disease

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115090) titled 'Molecular Mechanisms and Clinical Translation of GSTM3-Regulated Lipid Metabolic Reprogramming for the Treatment of Non-Alcoholic Fatty Liver Disease' on Dec. 22, 2025.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: The Affiliated Hospital of Guangdong Medical University

Condition: Non-alcoholic fatty liver disease

Intervention: Case group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-01-01

Target Sample Size: Case group:74;Control group:74;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj...